Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 26Leukemia, Myeloid, Acute 25Myelodysplastic Syndromes 21Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myeloproliferative Disorders 12Neoplasms 11Leukemia, Myelomonocytic, Chronic 10Anemia 10Lymphoma, Non-Hodgkin 9Hematologic Neoplasms 9Primary Myelofibrosis 8Anemia, Aplastic 8Thrombocytopenia 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Multiple Myeloma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Febrile Neutropenia 6Fanconi Anemia 6Congenital Bone Marrow Failure Syndromes 6Venous Thrombosis 5Pulmonary Embolism 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Follicular 5Recurrence 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Cytopenia 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sepsis × Classical hematology × 90 days × Clear all
NCT07277387 2026-04-23

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Instituto de Investigación Biomédica de Salamanca

Not yet recruiting
350 enrolled
Classical hematologyOther hematologic neoplasm

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡